Results from a Phase 3 clinical trial offer new hope for patients with previously treated advanced pancreatic cancer, showing the experimental drug daraxonrasib significantly extended survival compared with chemotherapy alone. Researchers at the University of Oklahoma Health Stephenson Cancer Center enrolled patients in the global trial.
Two University of Oklahoma College of Medicine faculty members, Mary Moon, Ph.D., and Priyabrata Mukherjee, Ph.D., were honored recently for their excellence in teaching and research. Moon received the 2026 Stanton L. Young Master Teacher Award, and Mukherjee received the Stanton L. Young Excellence in Research Award.
Tiny white coats, stuffed‑animal patients and big imaginations filled OU School of Community Medicine at OU–Tulsa recently as elementary‑aged children from across the Tulsa area stepped into the world of medicine during Doctor for a Day, a highly visual, hands‑on experience designed to spark curiosity about health care careers—and make the doctor’s office feel a little...
The Hudson Fellows in Public Health Program – a select group of doctoral students at the University of Oklahoma Hudson College of Public Health – will observe its 10th anniversary on April 9 with the annual Hudson Fellows Symposium. The event will feature a noontime lecture by health innovation leader Vivian S. Lee, M.D., Ph.D., MBA.
The Hudson Fellows in Public Health...
A hormone that reverses obesity in mice appears to work by signaling to a brain region involved in metabolism and appetite regulation, the same area targeted by the popular GLP-1 drugs. The finding, from University of Oklahoma researchers, is published in Cell Reports.
The study provides valuable new insight into the naturally occurring hormone, called FGF21 (fibroblast growth factor...
A powerful new $16 million cyclotron is arriving soon at the University of Oklahoma College of Pharmacy, marking a major expansion of advanced medical imaging, cancer treatment and research capabilities for patients across the state.
The GE HealthCare PETtrace 890 Cyclotron, acquired in collaboration with GE HealthCare and Cyclomedical International, will enable OU to produce advanced...
For the millions of people living with lupus – a chronic autoimmune disease that can damage the kidneys, brain and other vital organs – treatment options remain limited and often come with serious side effects. A $1.7 million grant from the National Institutes of Health will allow a University of Oklahoma researcher to continue investigating a protein that may help explain why the...
On Saturday, the University of Oklahoma College of Dentistry provided free cleanings, fillings and crowns to 109 children during the college’s annual Kids’ Day. The event was sponsored in part by the Delta Dental of Oklahoma Foundation and was held at the college in Oklahoma City. February is Children’s Oral Health Month.
OU College of Dentistry students provided the care...
OKLAHOMA CITY – People experiencing homelessness often live with chronic illness, mental health conditions and substance use disorders, while facing significant barriers to accessing and managing health care. With a new five-year, $1 million federal grant, the University of Oklahoma is addressing this challenge by launching a Street Medicine and Advocacy Pathway at the OU...
OKLAHOMA CITY –The University of Oklahoma Health Campus was recently recognized for its increased momentum in advancing discoveries that change lives, achieving the state’s first Top 100 national ranking based on funding from the National Institutes of Health, according to the Blue Ridge Institute for Medical Research. The ranking—the highest in OU’s history and in...